59 related articles for article (PubMed ID: 16620920)
1. Renal failure causes early death of bcl-2 deficient mice.
Fedorov LM; Schmittwolf C; Amann K; Thomas WH; Müller AM; Schubert H; Domen J; Kneitz B
Mech Ageing Dev; 2006 Jul; 127(7):600-9. PubMed ID: 16620920
[TBL] [Abstract][Full Text] [Related]
2. The impact of genetic background and Bid on the phenotype of Bcl-2-deficiency in mice.
Ni HM; Chen X; Chen L; DiFrancesca D; Harada H; Yin XM
Apoptosis; 2008 Jan; 13(1):53-62. PubMed ID: 17955375
[TBL] [Abstract][Full Text] [Related]
3. bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine.
Kamada S; Shimono A; Shinto Y; Tsujimura T; Takahashi T; Noda T; Kitamura Y; Kondoh H; Tsujimoto Y
Cancer Res; 1995 Jan; 55(2):354-9. PubMed ID: 7812968
[TBL] [Abstract][Full Text] [Related]
4. E2F1-/- C57BL/6 mice overexpressing a human Bcl-2 transgene in B cells develop a mild autoimmune syndrome.
Marín MJ; García I; Peña M; Bolívar A; Zubiaga A; Lóez-Hoyos M
Ann N Y Acad Sci; 2005 Jun; 1051():156-65. PubMed ID: 16126955
[TBL] [Abstract][Full Text] [Related]
5. Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1-deficient mouse.
Yoo KH; Kim YN; Lee MJ; Seong JK; Park JH
Proteomics; 2009 Aug; 9(15):3824-32. PubMed ID: 19637234
[TBL] [Abstract][Full Text] [Related]
6. Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro.
Zhang W; Pantschenko AG; McCarthy MB; Gronowicz G
Calcif Tissue Int; 2007 Feb; 80(2):111-22. PubMed ID: 17308993
[TBL] [Abstract][Full Text] [Related]
7. Somatic hypermutation of Ig genes is affected differently by failures in apoptosis caused by disruption of Fas (lpr mutation) or by overexpression of Bcl-2.
Mastache EF; Lindroth K; Fernández C; González-Fernández A
Scand J Immunol; 2006 Jun; 63(6):420-9. PubMed ID: 16764695
[TBL] [Abstract][Full Text] [Related]
8. Organ- and tissue-specific alterations in the anti-apoptotic protein Bcl-2 in CD1 female mice of different ages.
López-Araiza H; Ventura JL; López-Diazguerrero NE; González-Marquez H; Gutiérrez-Ruíz MC; Zentella A; Königsberg M
Biogerontology; 2006 Feb; 7(1):63-7. PubMed ID: 16518721
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair.
Veis DJ; Sorenson CM; Shutter JR; Korsmeyer SJ
Cell; 1993 Oct; 75(2):229-40. PubMed ID: 8402909
[TBL] [Abstract][Full Text] [Related]
10. Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cells.
McKenzie MD; Carrington EM; Kaufmann T; Strasser A; Huang DC; Kay TW; Allison J; Thomas HE
Diabetes; 2008 May; 57(5):1284-92. PubMed ID: 18252892
[TBL] [Abstract][Full Text] [Related]
11. Sustained cell proliferation of renal epithelial cells in mice with inv mutation.
Sugiyama N; Yokoyama T
Genes Cells; 2006 Oct; 11(10):1213-24. PubMed ID: 16999740
[TBL] [Abstract][Full Text] [Related]
12. Abnormal postpartum renal development and cystogenesis in the bcl-2 (-/-) mouse.
Sorenson CM; Padanilam BJ; Hammerman MR
Am J Physiol; 1996 Jul; 271(1 Pt 2):F184-93. PubMed ID: 8760259
[TBL] [Abstract][Full Text] [Related]
13. BCL-2 counteracts Doppel-induced apoptosis of prion-protein-deficient Purkinje cells in the Ngsk Prnp(0/0) mouse.
Heitz S; Gautheron V; Lutz Y; Rodeau JL; Zanjani HS; Sugihara I; Bombarde G; Richard F; Fuchs JP; Vogel MW; Mariani J; Bailly Y
Dev Neurobiol; 2008 Feb; 68(3):332-48. PubMed ID: 18085563
[TBL] [Abstract][Full Text] [Related]
14. The Bcl-2 family in autoimmune and degenerative disorders.
Mérino D; Bouillet P
Apoptosis; 2009 Apr; 14(4):570-83. PubMed ID: 19172396
[TBL] [Abstract][Full Text] [Related]
15. Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice.
Sorenson CM; Rogers SA; Korsmeyer SJ; Hammerman MR
Am J Physiol; 1995 Jan; 268(1 Pt 2):F73-81. PubMed ID: 7840250
[TBL] [Abstract][Full Text] [Related]
16. Using transgenic mice to analyze the mechanisms of progression of chronic renal failure.
Terzi F; Burtin M; Friedlander G
J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S144-8. PubMed ID: 11065347
[TBL] [Abstract][Full Text] [Related]
17. Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.
Stayner C; Iglesias DM; Goodyer PR; Ellis L; Germino G; Zhou J; Eccles MR
Hum Mol Genet; 2006 Dec; 15(24):3520-8. PubMed ID: 17082250
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ
Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944
[TBL] [Abstract][Full Text] [Related]
19. c-Maf interacts with c-Myb to down-regulate Bcl-2 expression and increase apoptosis in peripheral CD4 cells.
Peng S; Lalani S; Leavenworth JW; Ho IC; Pauza ME
Eur J Immunol; 2007 Oct; 37(10):2868-80. PubMed ID: 17823980
[TBL] [Abstract][Full Text] [Related]
20. Triggering of apoptosis by Puma is determined by the threshold set by prosurvival Bcl-2 family proteins.
Callus BA; Moujallad DM; Silke J; Gerl R; Jabbour AM; Ekert PG; Vaux DL
J Mol Biol; 2008 Dec; 384(2):313-23. PubMed ID: 18835564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
